Search clinical trials for: Abiraterone acetate plus degarelix
Total 342 results
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
Ferring PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompletedProstate CancerBelgium, Germany, Hungary, Netherlands, Romania, Russian Federation, South Africa
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Active, not recruitingProstate CancerUnited States
-
University of Colorado, DenverActive, not recruitingMenopause | Aging | Estrogen Deficiency | WomenUnited States
-
Janssen Research & Development, LLCCompleted
-
Cougar Biotechnology, Inc.Completed
-
Cougar Biotechnology, Inc.Completed
-
Cougar Biotechnology, Inc.CompletedProstate NeoplasmsUnited Kingdom, United States
-
Janssen Research & Development, LLCCompletedHealthy ParticipantsUnited States
-
M.D. Anderson Cancer CenterBlue Earth TherapeuticsRecruiting
-
Kenneth Pienta, MDProstate Cancer Foundation NorwayWithdrawnProstate Cancer | Localized Prostate CancerUnited States
-
BayerCompleted
-
Assistance Publique - Hôpitaux de ParisJanssen, LPCompletedProstate CancerFrance
-
Janssen Research & Development, LLCCompleted
-
The Affiliated Hospital of Qingdao UniversityCompletedHealthy VolunteersChina
-
Cougar Biotechnology, Inc.Completed
-
Fundación Pública Andaluza para la gestión de la...Completed
-
West China HospitalNot yet recruitingProstatic Neoplasms, Castration-Resistant | Drug Therapy, CombinationChina
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health... and other collaboratorsUnknownProstate Cancer | Metastasis | Toxicity Due to Radiotherapy | Circulating Tumour DNAUnited Kingdom
-
Ferring PharmaceuticalsTerminatedProstate CancerUnited States, Netherlands, United Kingdom, Hungary, Belgium, Czech Republic, Finland, Germany, Mexico, Poland, Romania, Ukraine, Canada
-
Universität des SaarlandesCompleted
-
AstraZenecaActive, not recruitingSevere Eosinophilic AsthmaChina
-
Sun Pharmaceutical Industries LimitedCompletedProstate CancerUnited States
-
AstraZenecaCompletedAsthmaUnited States, Belgium, United Kingdom, France, Portugal, Australia, Spain
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, Spain, China, United States, United Kingdom, France, Belgium, Taiwan, Australia, Hungary, Poland, Czechia, Russian Federation
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Fudan UniversityRecruiting
-
Massachusetts General HospitalActive, not recruiting
-
Cougar Biotechnology, Inc.Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed21-hydroxylase DeficiencyUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsFrance, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Canada, Netherlands, Sweden, New Zealand and more
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited Kingdom
-
Zhongnan HospitalActive, not recruitingPharmacokinetic | Abiraterone Acetate | Plasma Concentration | Gene Polymorphism | Metabolic AnalysisChina
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
Guangzhou University of Traditional Chinese MedicineCancer Institute and Hospital, Chinese Academy of Medical SciencesUnknown
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Urology of VirginiaFerring PharmaceuticalsCompletedProstate CancerUnited States
-
Jianbin BiNot yet recruitingMetastatic Hormone-Sensitive Prostate Cancer
-
PfizerAstellas Pharma IncCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
Aurelius OmlinUniversity Hospital, Basel, Switzerland; Cantonal Hospital of St. GallenTerminated
-
Cancer Research UKCompletedBreast CancerUnited Kingdom
-
University Health Network, TorontoCompletedCastration-resistant Prostate CancerCanada
-
Ding-Wei YeNot yet recruitingAbiraterone Acetate | MCRPC (metastatic Castration-resistant Prostate Cancer)China
-
PfizerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
University of California, San FranciscoJohnson & Johnson; Cougar Biotechnology, Inc.Completed